Steris plc reported financial results for the third quarter (Q3) of fiscal 2026, with total revenue from continuing operations rising 9% to USD 1.5 billion for the period ended December 31, 2025. Net income from continuing operations for Q3 reached USD 192.9 million, with earnings per diluted share at USD 1.96. Adjusted net income was USD 249.4 million, and adjusted earnings per diluted share stood at USD 2.53 for the quarter. The Applied Sterilization Technologies segment reported Q3 revenue of USD 286.6 million, reflecting an 11% increase. Within this segment, service revenue grew by 9%, while capital equipment revenue increased more than twofold. Segment operating income was USD 129.2 million for Q3. Steris plc anticipates capital expenditures of approximately USD 375 million and free cash flow of around USD 850 million for the fiscal year. The company stated that high single-digit revenue growth and cost discipline enabled meaningful earnings per share growth despite increased tariff headwinds. The fiscal 2026 outlook has been maintained.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Steris plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9649061-en) on February 04, 2026, and is solely responsible for the information contained therein.